Ignite Creation Date:
2025-12-24 @ 4:17 PM
Ignite Modification Date:
2026-01-24 @ 10:32 PM
Study NCT ID:
NCT02077166
Status:
COMPLETED
Last Update Posted:
2022-02-04
First Post:
2014-02-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ibrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Sponsor:
Pharmacyclics LLC.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-03-13
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-12-17
Completion Date Type:
ACTUAL
First Submit Date:
2014-02-10
First Submit QC Date:
None
Study First Post Date:
2014-03-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-11-30
Results First Submit QC Date:
None
Results First Post Date:
2022-02-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-06
Last Update Post Date:
2022-02-04
Last Update Post Date Type:
ACTUAL